Orchestra BioMed Holdings, Inc. SEC filings OBIO

Orchestra BioMed Holdings, Inc. has 412 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Orchestra BioMed Holdings, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Nov 5, 2026 —
4 Insider transaction Nov 3, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 2, 2026 —
4 Insider transaction Oct 2, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Oct 1, 2026 Oct 1, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 2, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Aug 28, 2026 Aug 26, 2026
4 Insider transaction Aug 28, 2026 Aug 26, 2026
4 Insider transaction Aug 28, 2026 Aug 26, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
4 Insider transaction Aug 4, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
4 Insider transaction Jul 2, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
8-K Current report
Shareholder vote results
Jun 23, 2026 Jun 23, 2026
S-8 Employee stock plan registration Jun 23, 2026 —
DEFA14A Additional proxy material Jun 16, 2026 —
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 29, 2026 May 28, 2026
4 Insider transaction May 20, 2026 May 18, 2026
4 Insider transaction May 19, 2026 May 15, 2026
4 Insider transaction May 19, 2026 May 15, 2026
4 Insider transaction May 18, 2026 May 14, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 29, 2026 —
4 Insider transaction Apr 29, 2026 Apr 27, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 23, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 27, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 25, 2026 —
4 Insider transaction Feb 13, 2026 Feb 12, 2026
4 Insider transaction Feb 13, 2026 Feb 12, 2026
4 Insider transaction Feb 13, 2026 Feb 12, 2026
8-K Current report
Officer or director change
Feb 13, 2026 Feb 12, 2026
4 Insider transaction Feb 13, 2026 Feb 12, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
S-8 Employee stock plan registration Feb 6, 2026 —
S-8 Employee stock plan registration Feb 6, 2026 —
4 Insider transaction Feb 6, 2026 Jan 28, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Nov 26, 2025 Nov 25, 2025
4 Insider transaction Nov 26, 2025 Nov 25, 2025
424B3 Prospectus Nov 21, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 19, 2025 —
4 Insider transaction Nov 17, 2025 Nov 14, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Regulation FD disclosure
Nov 13, 2025 Nov 12, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
S-3 Shelf registration Oct 31, 2025 —
8-K Current report
Regulation FD disclosure
Oct 30, 2025 Oct 30, 2025
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
Oct 28, 2025 Oct 24, 2025
4 Insider transaction Sep 19, 2025 Sep 19, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
4 Insider transaction Sep 5, 2025 Sep 3, 2025
4 Insider transaction Aug 25, 2025 Aug 25, 2025
4 Insider transaction Aug 25, 2025 Aug 25, 2025
4 Insider transaction Aug 25, 2025 Aug 21, 2025
4 Insider transaction Aug 25, 2025 Aug 25, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 6, 2025 —
4 Insider transaction Aug 6, 2025 Aug 4, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 4, 2025 Aug 4, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Aug 4, 2025 Jul 31, 2025
424B5 Prospectus supplement Aug 1, 2025 —
424B5 Prospectus supplement Jul 31, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure, Other events
Jul 31, 2025 Jul 31, 2025
4 Insider transaction Jun 27, 2025 Jun 26, 2025
4 Insider transaction Jun 27, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
144 Notice of proposed sale Jun 26, 2025 —
8-K Current report
Shareholder vote results
Jun 24, 2025 Jun 24, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction May 30, 2025 May 28, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 1, 2025 —
4 Insider transaction May 1, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 24, 2025
4 Insider transaction Apr 29, 2025 Apr 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 29, 2025 Apr 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 29, 2025 —
4 Insider transaction Apr 4, 2025 Apr 4, 2025
4 Insider transaction Apr 4, 2025 Apr 4, 2025
4 Insider transaction Apr 4, 2025 Apr 4, 2025
4 Insider transaction Apr 4, 2025 Apr 4, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
4 Insider transaction Mar 28, 2025 Mar 26, 2025
4 Insider transaction Mar 7, 2025 Mar 7, 2025
8-K Current report
Regulation FD disclosure
Mar 3, 2025 Mar 3, 2025
8-K Current report
Officer or director change
Feb 25, 2025 Feb 19, 2025
S-8 Employee stock plan registration Feb 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 5, 2025 Feb 3, 2025
3 Initial insider ownership Feb 5, 2025 Jan 30, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 5, 2025 Jan 30, 2025
4 Insider transaction Dec 30, 2024 Dec 27, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 19, 2024 Dec 18, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 6, 2024 Dec 5, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G Ownership over 5% (passive) Oct 23, 2024 —
4 Insider transaction Sep 26, 2024 Sep 24, 2024
4 Insider transaction Sep 10, 2024 Sep 9, 2024
4 Insider transaction Sep 10, 2024 Sep 6, 2024
144 Notice of proposed sale Sep 10, 2024 —
144 Notice of proposed sale Sep 10, 2024 —
144 Notice of proposed sale Sep 9, 2024 —
144 Notice of proposed sale Sep 9, 2024 —
4 Insider transaction Sep 6, 2024 Sep 4, 2024
144 Notice of proposed sale Sep 6, 2024 —
144 Notice of proposed sale Sep 6, 2024 —
144 Notice of proposed sale Sep 5, 2024 —
144 Notice of proposed sale Sep 4, 2024 —
4 Insider transaction Aug 15, 2024 Aug 14, 2024
8-K Current report
Other events
Aug 12, 2024 Aug 12, 2024
424B5 Prospectus supplement Aug 12, 2024 —
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
4 Insider transaction Aug 8, 2024 Aug 7, 2024
SC 13D/A Amended ownership over 5% (active) Aug 7, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 7, 2024 —
4 Insider transaction Aug 7, 2024 Aug 5, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 30, 2024 Jul 29, 2024
3 Initial insider ownership Jul 30, 2024 Jul 29, 2024
3 Initial insider ownership Jul 17, 2024 Jul 11, 2024
SC 13G/A Amended ownership over 5% (passive) Jul 17, 2024 —
4 Insider transaction Jun 26, 2024 Jun 25, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
8-K Current report
Shareholder vote results
Jun 20, 2024 Jun 20, 2024
8-K Current report
Regulation FD disclosure
Jun 11, 2024 Jun 11, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
EFFECT Filing May 24, 2024 —
424B3 Prospectus May 24, 2024 —
CORRESP Letter to the SEC May 22, 2024 —
4/A Ownership document May 21, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 16, 2024
UPLOAD Letter from the SEC May 20, 2024 —
S-3 Shelf registration May 15, 2024 —
10-Q Quarterly report May 13, 2024 Mar 31, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 10, 2024 May 8, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
OBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Hope, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1814114
Former names
Health Sciences Acquisitions Corp 2 (until Jan 26, 2023)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.